erlotinib hydrochloride has been researched along with cantharidin in 2 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (cantharidin) | Trials (cantharidin) | Recent Studies (post-2010) (cantharidin) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 875 | 27 | 307 |
Protein | Taxonomy | erlotinib hydrochloride (IC50) | cantharidin (IC50) |
---|---|---|---|
Protein phosphatase 1B | Homo sapiens (human) | 1.78 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 3.6 | |
Serine/threonine-protein phosphatase PP1-gamma catalytic subunit | Homo sapiens (human) | 1.78 | |
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B | Gallus gallus (chicken) | 0.63 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gong, FR; Li, W; Liu, ZY; Shen, M; Tao, M; Wang, WJ; Wu, MY; Zhi, Q | 1 |
He, M; Ji, XL | 1 |
2 other study(ies) available for erlotinib hydrochloride and cantharidin
Article | Year |
---|---|
Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib.
Topics: Apoptosis; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Cantharidin; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Erlotinib Hydrochloride; Gemcitabine; Humans; Neoplastic Stem Cells; Pancreatic Neoplasms; Phosphorylation; Signal Transduction | 2015 |
Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma.
Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cantharidin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Child; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Mice; Mice, Nude; Osteosarcoma; Phosphorylation; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2019 |